Renalis develops digital therapy solutions to treat pelvic health disorders and is based in Cleveland, OH. Led by CEO Missy Lavender, its first digital therapeutic product, CeCe, enables patients to record and manage symptoms of Overactive Bladder (OAB) via a mobile application. The company plans to expand its pipeline to therapeutics for menstrual disorders, stress incontinence, bowel dysfunction, chronic pelvic pain, and other solutions for all persons with a pelvis when applicable. Renalis raised $824K in Pre-Seed funding to amplify research within healthcare systems such as University Hospitals, support regulatory efforts, and strategically build a team to lead commercialization and technology efforts. The company positions its offerings within healthcare systems and intends to leverage clinical partnerships to advance product development and commercialization.

Total raised

$1M

Funding rounds

1

Latest round

Seed

Latest activity

Sep 2021